Universitätsklinikum Tübingen

P53 AND P16 EXPRESSION PROFILES IDENTIFY THREE PROGNOSTICALLY SUBGROUPS IN VULVAR CANCER: A TMA BASED STUDY BY THE AGO-CARE-TRANSLATIONAL STUDY GROUP (2019) Woelber L, Prieske K, Eulenburg C, De Gregorio N, Klapdor R, Kalder M, Braicu I, et al. Conference contribution Fatigue and depression predict health-related quality of life in patients with pediatric-onset multiple sclerosis (2019) Gravesande KSV, Blaschek A, Calabrese P, Rostasy K, Huppke P, Kessler JJ, Kalbe E, et al. Journal article Quantitative, multi-institutional evaluation of MR thermometry accuracy for deep-pelvic MR-hyperthermia systems operating in multi-vendor MR-systems using a new anthropomorphic phantom (2019) Curto S, Aklan B, Mulder T, Mils O, Schmidt M, Lamprecht U, Peller M, et al. Journal article First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: A retrospective observational multicentre study (2019) Menzler K, Mross PM, Rosenow F, Schubert-Bast S, Willems LM, Zahnert F, Immisch I, et al. Journal article A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours (2019) Krauss J, Eigentler T, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution CLINICAL AND VIROLOGICAL CHARACTERISTICS AND RETREATMENT OF HCV-INFECTED PATIENTS WITH FAILURE TO MULTIPLE SUBSEQUENT DAA THERAPIES (2019) Dietz J, Vermehren J, Peiffer KH, Wietzke-Braun P, Muellhaupt B, Schattenberg J, Antoni C, et al. Conference contribution Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article Correction to: Curriculum for sports cardiology (Der Kardiologe, (2019), 13, 1, (26-37), 10.1007/s12181-019-0299-0) Erratum zu: Curriculum Sportkardiologie (Der Kardiologe, (2019), 13, 1, (26-37), 10.1007/s12181-019-0299-0) (2019) Burgstahler C, Pressler A, Berrisch-Rahmel S, Mellwig KP, Bongarth C, Halle M, Niebauer J, et al. Journal article, Erratum